Literature DB >> 17482402

Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?

A Simm1, J Wagner, T Gursinsky, N Nass, I Friedrich, R Schinzel, E Czeslik, R E Silber, R J Scheubel.   

Abstract

OBJECTIVE: A decline in the function of all organs can be detected during ageing. Although the trend appears to be stable, deviation within the elderly population is much greater in comparison to young controls. The aim of the study was to identify a marker of senescence which correlates to heart function. Advanced glycation endproducts (AGEs) accumulate with age and are associated with degenerative diseases.
METHODS: Carboxymethyllysine (CML) concentrations in the pericardial fluid (as a measure of AGEs) were analysed with ELISA technique in 75 patients undergoing cardiac surgery and correlated with clinical parameters and outcome of these patients.
RESULTS: CML content of pericardial fluid increases significantly with age. AGEs show an inverse correlation to left ventricular ejection fraction. High CML levels correlate with poor outcome of patients as shown by adverse cardiac events, prolonged ventilation time and prolonged stay within the Intensive Care Unit. Within all parameters, AGE concentration of the pericardial fluid fits better with the outcome of the patients in comparison to age alone. Interestingly, medical treatment with nitrates correlates with increased CML content.
CONCLUSION: AGEs, in addition to being a marker of senescence, appear to represent a prognostic factor in cardiac surgery, which can be used as a predictor of patient outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482402     DOI: 10.1016/j.exger.2007.03.006

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  33 in total

Review 1.  Advanced glycation end products, diabetes and ageing.

Authors:  N Nass; B Bartling; A Navarrete Santos; R J Scheubel; J Börgermann; R E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

Review 2.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

3.  Differences in non-enzymatic glycation products in human dentine and clavicle: changes with aging.

Authors:  Aurora Valenzuela; Eduardo Guerra-Hernández; José Ángel Rufián-Henares; Ana Belén Márquez-Ruiz; Hans Petter Hougen; Belén García-Villanova
Journal:  Int J Legal Med       Date:  2018-08-01       Impact factor: 2.686

4.  Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation.

Authors:  Robertina Giacconi; Andreas Simm; Alexander Navarrete Santos; Laura Costarelli; Marco Malavolta; Patrizia Mecocci; Francesco Piacenza; Andrea Basso; Tamas Fulop; Lothar Rink; George Dedoussis; Stavroula Kanoni; Georges Herbein; Jolanta Jajte; Eugenio Mocchegiani
Journal:  Genes Nutr       Date:  2014-08-23       Impact factor: 5.523

Review 5.  Diabetes Mellitus and Heart Failure.

Authors:  Dimitris Tousoulis; Evangelos Oikonomou; Gerasimos Siasos; Christodoulos Stefanadis
Journal:  Eur Cardiol       Date:  2014-07

Review 6.  A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.

Authors:  Shehwaz Anwar; Shifa Khan; Ahmad Almatroudi; Amjad Ali Khan; Mohammed A Alsahli; Saleh A Almatroodi; Arshad Husain Rahmani
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

Review 7.  [Biofunctional age diagnosis in humans. Potentials and limits].

Authors:  D Pöthig; W Gerdes; M Viol; P Wagner; A Simm
Journal:  Z Gerontol Geriatr       Date:  2011-06       Impact factor: 1.281

8.  Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.

Authors:  Wendela L Greven; Jitty M Smit; Johannes H Rommes; Peter E Spronk
Journal:  BMC Clin Pathol       Date:  2010-05-25

9.  Infusion fluids contain harmful glucose degradation products.

Authors:  Anna Bryland; Marcus Broman; Martin Erixon; Bengt Klarin; Torbjörn Lindén; Hans Friberg; Anders Wieslander; Per Kjellstrand; Claudio Ronco; Ola Carlsson; Gabriela Godaly
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

10.  Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.

Authors:  Jianfei Chen; Minbao Song; Shiyong Yu; Pan Gao; Yang Yu; Hong Wang; Lan Huang
Journal:  Mol Cell Biochem       Date:  2009-09-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.